MedPath

Comparison of the effect of apixaban and enoxaparin on the prevention of postoperative vascular thromboembolism

Phase 3
Recruiting
Conditions
Venous embolism and thrombosis.
Other venous embolism and thrombosis
Registration Number
IRCT20141231020504N2
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
200
Inclusion Criteria

Patients diagnosed with gynecological cancers (ovarian, uterine, cervical, or vulvar) undergo laparotomy surgery.

Exclusion Criteria

Long-term use of non-steroidal anti-inflammatory drugs
Patients with coagulation or bleeding disorders, severe kidney or liver diseases, valvular heart diseases
Using thrombogenic drugs, selective serotonin reuptake inhibitors, or serotonin-norepinephrine reuptake inhibitors
History of venous thromboembolism

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Major bleeding incidence. Timepoint: Once, 30 days after the surgery. Method of measurement: Questioning.;Non-major bleeding incidence with clinical significance (requiring intervention). Timepoint: Once, 30 days after the surgery. Method of measurement: Questioning.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath